ROS-mediated Amplification of AKT/mTOR Signalling Pathway Leads to Myeloproliferative Syndrome in Foxo3−/− Mice

EMBO Journal - Germany
doi 10.1038/emboj.2010.292
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports
Multidisciplinary
2017English

Reversal of Muscle Atrophy by Zhimu-Huangbai Herb-Pair via Akt/mTOR/FoxO3 Signal Pathway in Streptozotocin-Induced Diabetic Mice

PLoS ONE
Multidisciplinary
2014English

Xihuang Pill Induces Apoptosis of Human Glioblastoma U-87 MG Cells via Targeting ROS-Mediated Akt/mTOR/Foxo1 Pathway

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2018English

Linc01014 Regulates Gefitinib Resistance in Oesophagus Cancer via EGFR‐PI3K‐AKT‐mTOR Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Necessity to Evaluate PI3K/Akt Signalling Pathway in Proarrhythmia

Open Heart
Cardiovascular MedicineCardiology
2017English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Targeting the Akt/mTOR Pathway in Brca1-Deficient Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Cigarette Smoke Exposure Induces ROS-mediated Autophagy by Regulating Sestrin, AMPK, and mTOR Level in Mice

Redox Report
BiochemistryClinical BiochemistryCell BiologyPhysiology
2019English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy